Evidence map›Paper›PMID 34578972›Full record

ReviewNutrients2021

Enhancing Bioavailability of Nutraceutically Used Resveratrol and Other Stilbenoids.

Ondrej Vesely, Simona Baldovska, Adriana Kolesarova

Abstract readReview
In one paragraph

Review in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Evaluation of Molecular Responses and Longevity Markers inInternational journal of molecular sciences · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Nanomaterials (Basel, Switzerland) · 2025
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ondrej VeselyDepartment of Food Science, The Faculty of Agrobiology, Food and Natural Resources, The Czech University of Life Sciences Prague, 16500 Prague, Czech Republic.ORCID 0000-0002-9624-2965
Simona BaldovskaAgroBioTech Research Centre, Slovak University of Agriculture in Nitra, 94976 Nitra, Slovakia.ORCID 0000-0002-9336-764X
Adriana KolesarovaDepartment of Animal Physiology, Faculty of Biotechnology and Food Sciences, Slovak University of Agriculture in Nitra, 94976 Nitra, Slovakia.

Funding

ERASMUS+ Programme of the European Union KA2 2020-1-SK01-KA203-078363Kultúrna a Edukacná Grantová Agentúra MŠVVaŠ SR KEGA 033SPU-4/2021Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky APVV-18-0312Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky DS-FR-19-0049the Operational Programme Integrated Infrastructure within the project: Demand-driven research for the sustainable and innovative food Drive4SIFood 313011V336Vedecká Grantová Agentúra MŠVVaŠ SR a SAV VEGA 1/0266/20
6 · The paper itself

Abstract

Stilbenoids are interesting natural compounds with pleiotropic in vitro and in vivo activity. Their well-documented biological properties include anti-inflammatory effects, anticancer effects, effects on longevity, and many others. Therefore, they are nowadays commonly found in foods and dietary supplements, and used as a part of treatment strategy in various types of diseases. Bioactivity of stilbenoids strongly depends on different types of factors such as dosage, food composition, and synergistic effects with other plant secondary metabolites such as polyphenols or vitamins. In this review, we summarize the existing in vitro, in vivo, and clinical data from published studies addressing the optimization of bioavailability of stilbenoids. Stilbenoids face low bioavailability due to their chemical structure. This can be improved by the use of novel drug delivery systems or enhancers, which are discussed in this review. Current in vitro and in vivo evidence suggests that both approaches are very promising and increase the absorption of the original substance by several times. However, data from more clinical trials are required.

Indexed as

AnimalsBiological AvailabilityDietary SupplementsDrug Delivery SystemsHumansResveratrolStilbenesResveratrolStilbenesbioavailabilitybioenhancersmetabolismresveratrol

Identifiers

PMID34578972
PMCPMC8470508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.